Skip to main content
Oncocross Co.,Ltd. logo

Oncocross Co.,Ltd. — Investor Relations & Filings

Ticker · 382150 ISIN · KR7382150001 KO Professional, scientific and technical activities
Open in API
Filings indexed 106 across all filing types
Latest filing 2026-05-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 382150

About Oncocross Co.,Ltd.

https://www.oncocross.com/en

Oncocross is an artificial intelligence (AI) biotechnology company specializing in drug development. The company utilizes proprietary AI platforms, including RAPTOR AI™, which analyze a comprehensive, medically curated transcriptome database of patients, drugs, and diseases. This technology is used to predict interactions between drugs and diseases, enabling the identification of optimal indications for new and existing compounds. Oncocross focuses on developing treatments for cancer, rare diseases, and other intractable conditions. Its approach aims to accelerate the drug development process, reduce costs, and increase the success rate of clinical trials by identifying promising drug candidates and expanding their potential applications.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 93% confidence The document is clearly labeled ‘분기보고서’ (quarterly report) covering the period 2026-01-01 to 2026-03-31. It includes comprehensive financial statements, notes, management discussion, and audit opinions. It is not just an announcement or attach-link notice but the full interim financial report itself. Therefore, it matches the definition of an Interim/Quarterly Report (IR). Q1 2026
2026-05-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 92% confidence The document is a regulatory filing detailing an executive’s (director’s) securities ownership and changes thereto, including dates, share counts, and transaction details (e.g., gift of shares from spouse). This matches an insider transaction report by a company director, fitting the ‘Director’s Dealing’ category.
2026-04-27 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 92% confidence The document is a mandatory corporate disclosure (Korea) concerning the grant of stock purchase options (주식매수선택권 부여). It details correction of the initial grant notice, fair value calculations, and allocation of options to executives. This relates to an issuance of new equity-linked instruments and thus falls under 'Share Issue/Capital Change'. It is not a mere announcement of a report, nor is it an earnings release, board management change, or insider trade. Therefore, the appropriate classification is SHA (Share Issue/Capital Change).
2026-04-23 Korean
[기재정정]주요사항보고서(회사합병결정)
M&A Activity Classification · 90% confidence The document is a formal “주요사항보고서(회사합병 결정)” filed with the Korea Exchange and Financial Services Commission, providing extensive details on the absorption‐type merger between the listed company (Oncocross) and an unlisted company (Oncomaster). It outlines the merger rationale, financial impact, merger ratio calculations, external valuation, timelines, and legal provisions—all hallmarks of an M&A announcement. There is no indication that this is simply a publication notice or a proxy solicitation; it is the substantive merger‐activity disclosure itself. Hence, it best fits the M&A Activity category.
2026-04-16 Korean
주요사항보고서(회사합병결정)
M&A Activity Classification · 93% confidence The document is a “주요사항보고서(회사합병 결정)” filed with the Korean Financial Supervisory Service and Korea Exchange. It details the decision to absorb-merge one company into another, including merger rationale, legal basis, share exchange ratio, external valuation, timetable, and related procedures. This is a formal M&A announcement, not a corporate annual report, earnings release, or board change notice. It directly corresponds to our M&A Activity category.
2026-04-15 Korean
주주명부폐쇄기간또는기준일설정
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is a Korean corporate disclosure setting the shareholder record date (주주명부폐쇄기간 또는 기준일 설정) to identify shareholders entitled to voting rights in a small-scale merger. It is not a full report but an announcement of voting rights procedures. Under our taxonomy, this falls under Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-04-15 Korean

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.